Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.
Press releases published on July 29, 2025

Amid Federal Budget Cuts, Capital Project Toolkit Empowers Cities With AI-Driven Guidance
AI-powered Toolkit gives municipalities step-by-step guidance, editable templates, and cost-saving strategies to manage capital projects efficiently. NC, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- As federal and state budget cuts squeeze capital …

Friendship Institute Calls for a Global Friendship Reset on July 30, International Friendship Day
As Loneliness Surges and Workplace Disconnection Grows, the Friendship Institute Launches Bold New Tools for Building Meaningful Relationships CARY, NC, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- In a world that has never been more connected yet …

NetActuate Launches Standalone Consulting Service to Solve Complex Networking and AI Infrastructure Challenges
RALEIGH, NC, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- NetActuate, a leading global provider of network and infrastructure services, has announced the launch of a new, standalone consulting service. Designed to help businesses of all sizes …

reAlpha Mortgage launches as reAlpha’s AI-Enhanced Brokerage Arm, Supports Next Phase of Vertical Integration
COLUMBUS, Ohio, July 29, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced the launch of reAlpha Mortgage, the next chapter in the evolution of its …

Telix H1 2025 Results: Investor Webcast Notification
MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for the half-year ended 30 June 2025 on Thursday 21 August 2025 …

Ambiq Announces Pricing of Upsized Initial Public Offering
AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) -- Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the pricing of its upsized initial public offering of 4,000,000 shares of its common …

Datavault AI Debuts Enterprise Commercialization for AI Agents Built with IBM watsonx for AI-Powered Data Monetization
BEAVERTON, Ore., July 30, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (Nasdaq: DVLT), a leader in AI data experience, valuation, and monetization, today announced the expanded commercialization of its flagship AI agents—DataScore® and DataValue®— …

TransAlta Declares Dividends
CALGARY, Alberta, July 29, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC) declared a quarterly dividend of $0.065 per common share payable on Oct. 1, 2025, to shareholders of record at the close of business …

Flex Mobile Launches First-Ever Premium Membership Model in Prepaid Wireless
Los Angeles, CA, July 29, 2025 (GLOBE NEWSWIRE) -- Flex Mobile has officially launched its premium membership experience for prepaid wireless customers, introducing a first-of-its-kind customer rewards program that transforms a basic phone plan into a …

Treatment.com AI Engages Market Maker
Vancouver, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; 939: FRA) has engaged the services of Independent Trading Group ("ITG") pursuant to an agreement dated and starting …

Kneat to Announce 2025 Second-Quarter Financial Results August 5, 2025
LIMERICK, Ireland, July 29, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial …

Rakovina Therapeutics Announces Stock Option Grants
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug …

Axonius Acquires Medical Device Security Specialist Cynerio for More Than $100 Million to Target Healthcare Market
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Axonius, the global leader in cyber asset intelligence, today announced that it has acquired Cynerio, a pioneer in medical device security for more than $100 million in a cash and stock transaction. The …

Silvaco to Acquire Mixel, Inc. a Provider of Low-Power, High-Performance Mixed-Signal Connectivity IP Solutions
SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (“Silvaco”) (NASDAQ: SVCO), a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, today …

DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report
Châtillon, France, July 29, 2025 DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage …

DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation
Châtillon, France, le 29 juillet 2025 DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société biopharmaceutique …

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
DURHAM, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2025 …

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results
Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, …

DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025
Châtillon, France, le 29 juillet 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : 23306J309), société biopharmaceutique …

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)
– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-to-treat population (N=110) – – Early PFS data show a trend favoring 30mg onvansertib dose arm vs. control arm – – Onvansertib …